drugset / Trial / NCT05117554
Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and tolerability, pharmacokinetic, and pharmacodynamic profile, and drug-drug interaction (DDI) of casdatifan in healthy participants.
Timeline
- Start
- 2021-11-09
- Primary completion
- 2023-02-17
- Completion
- 2023-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casdatifan | Small molecule | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |
Indications
No indication recorded.